BioNexus Gene Lab Corp. (BGLC)

OTCMKTS: BGLC · Delayed Price · USD
0.442
-0.037 (-7.72%)
Jun 14, 2024, 4:00 PM EDT - Market closed
Market Cap 7.81M
Revenue (ttm) 9.78M
Net Income (ttm) -2.66M
Shares Out 17.67M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 130,682
Open 0.450
Previous Close 0.479
Day's Range 0.435 - 0.450
52-Week Range 0.150 - 9.490
Beta 1.83
Analysts n/a
Price Target n/a
Earnings Date n/a

About BGLC

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its produ... [Read more]

Sector Materials
Founded 2017
Employees 30
Stock Exchange OTCMKTS
Ticker Symbol BGLC
Full Company Profile

Financial Performance

In 2023, BGLC's revenue was $9.77 million, a decrease of -10.60% compared to the previous year's $10.93 million. Losses were -$2.63 million, 638.6% more than in 2022.

Financial Statements

News

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

KUALA LUMPUR, Malaysia, April 19, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), a global leader in genomic diagnostics and healthcare technology, announces a strategic investm...

2 months ago - GlobeNewsWire

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”) (Nasdaq: BGLC), an emerging company in the business of selling chemical raw materials in...

11 months ago - GlobeNewsWire

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BioNexus” or the “Company”), an emerging company in the business of selling chemical raw materials in the Southeast ...

11 months ago - GlobeNewsWire